Bombay Founders’ Club Acquires Movement, previously ‘The Indian Startup Community’
The announcement was made at 'The Room' Event in MumbaiMUMBAI, India, April…
3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
3iQ Announces Earlier Than Anticipated Closing of Previously Disclosed Transaction with Coincheck Group N.V.
TORONTO, Feb. 24, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU)…
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of…
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
December 04, 2025 07:00 ET | Source: Vaxil Bio Ltd. Not for…
THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM — PREVIOUSLY SHOWN TO IMPROVE COGNITION — MAY ALSO IMPROVE SLEEP APNEA, BLOOD PRESSURE REGULATION, AND COGNITIVE RESILIENCE
- Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies -Key…
Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
September 26, 2025 15:57 ET | Source: Scilex Holding Company PALO ALTO,…
Boehringers HERNEXEOS approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
This press release is not intended for UK and US media. HERNEXEOS® (zongertinib…
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilexs Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a f
June 23, 2025 16:50 ET | Source: Scilex Holding Company PALO ALTO,…
